The management of disorders of gut-brain interaction based on their causes was a central topic addressed at NeuroGASTRO 2025. In this video interview, Dr. Javier Santos delves into the role of mast cells in postprandial symptoms and the present and future of microbiome-based interventions for bowel disorders.
The gut microbiome puzzle and probiotics in primary care patients with IBS
16 Feb 2026by GMFH Editing Team
Gut microbiome-related interventions for the management of disorders of gut-brain interaction were on the agenda of NeuroGASTRO 2025. In this video interview, Dr. Juan M. Mendive delves into the role of the gut microbiome for improving outcomes of primary care patients with IBS.
Specific probiotic species and strains could help manage chronic constipation in adults
2 Feb 2026by Andreu Prados
Chronic constipation affects around one in ten adults worldwide. The new British Dietetic Association’s guidelines show that psyllium, certain probiotic strains and magnesium oxide supplements can help to improve constipation.
Digestive Disease Week 2025 featured recent basic, translational, and clinical research into the microbiome. Find out more about the main takeaways relevant for your clinical practice selected by GMFH editors.
Emerging research suggests a complex interaction between the gut microbiome and endometriosis. Recent studies have begun to explore the impact of dietary interventions on endometriosis.
Clinical translation of microbiome research: takeaways from the 2025 GMFH Summit
16 May 2025by Andreu Prados
The 13th Gut Microbiota for Health World Summit took place 15-16 March 2025 in Washington, D.C., and it focused on advances in microbiome research to diagnose, prevent, and manage gastrointestinal and extra-intestinal conditions. Find out more about the most valuable takeaways from the event.
Carbohydrate malabsorption is an underlying cause of irritable bowel syndrome-type symptoms in some patients. This article explores the impact of fermentable short-chain carbohydrates (FODMAPs) on gut function, the benefits and risks of a low-FODMAP diet, and how probiotics can help individuals with carbohydrate malabsorption.
The fourth edition of IBS Days covered the latest IBS diagnosis and treatment advances in a postgraduate course. Read about the highlights and discussions (part 2).
IBS Days 2024: what’s new in the pathophysiology of IBS, overlapping conditions, and non-prescription microbiome-based therapeutics?
12 Aug 2024by Andreu Prados
June 17-19 2024, Gut Microbiota for Health attended the fourth edition of IBS Days 2024 in Bologna, Italy, alongside 400 in-person attendees. Find out more about the most relevant basic, translational, and clinical science highlights in IBS (part 1).
Unlocking the diagnostic and therapeutic potential roles of gut microbiome: takeaways from the 2024 GMFH Summit
23 May 2024by Joël Doré, Andreu Prados
The last 12th Gut Microbiota for Health World Summit took place 23-24 March 2024 in Washington, D.C. and focused on relevant gut microbiome advances from the lab to the clinic. Find out more about the main takeaways of the conference and how they might affect your research and practice.
